Org 27569 10mg 10mg | Purity Not Available
Adooq Bioscience
Org 27569 is a potent CB1 receptor allosteric modulator (pEC50 = 8.24).
More Information Supplier PageOrg 27569 is a potent CB1 receptor allosteric modulator (pEC50 = 8.24).
More Information Supplier PageNVP-BAG956 acts as a potent, reversible, and ATP-competitive PI 3-K/PDK1 dual kinase inhibitor, displaying much reduced potency against VEGFR1 (IC50 = 2.56 uM) and little or no activity toward a panel of 15 other kinases (IC50 >10 uM).
More Information Supplier PageNVP-BAG956 acts as a potent, reversible, and ATP-competitive PI 3-K/PDK1 dual kinase inhibitor, displaying much reduced potency against VEGFR1 (IC50 = 2.56 uM) and little or no activity toward a panel of 15 other kinases (IC50 >10 uM).
More Information Supplier PageNVP-BAG956 acts as a potent, reversible, and ATP-competitive PI 3-K/PDK1 dual kinase inhibitor, displaying much reduced potency against VEGFR1 (IC50 = 2.56 uM) and little or no activity toward a panel of 15 other kinases (IC50 >10 uM).
More Information Supplier PageNAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
More Information Supplier PageMK-2894 is a highly potent and selective second generation EP4 antagonist.
More Information Supplier PageMK-2894 is a highly potent and selective second generation EP4 antagonist.
More Information Supplier PageMK-2894 is a highly potent and selective second generation EP4 antagonist.
More Information Supplier PageMK-2894 is a highly potent and selective second generation EP4 antagonist.
More Information Supplier PageMotesanib (AMG706) is a multikinase inhibitor that selectively targets VEGF receptors, platelet-derived growth factor receptors (PDGFRs), and Kit receptors with IC?? values of 2 nM (VEGFR1), 3 nM (VEGFR2), 6 nM (VEGFR3), 84 nM (PDGFR), and 8 nM (Kit).
More Information Supplier Page